Aniridia and Beyond:PAX6, Eye Deficits, and Effects on Metabolic Disease
A conference on aniridia and related congenital eye disorders: for patients and their families, clinicians, and research investigators
July 31 - August 4, 2013
University of Virginia
July 31 - August 2 - Patient-oriented sessions including discussion of treatments for visual system, metabolic and sleep disorders, management of work and social interactions, and issues specific to children.
August 3 - A Clinical Symposium that focuses on current treatments for aniridia and is available for CME credit.
August 2 & 3 - Research Symposia featuring leading researchers studying regulation of PAX6 and other genes involved in eye development and disease, stem cell treatments for aniridia, clinical trials to repair PAX6 deficits, and the metabolism and obesity connection to PAX6 function.
For more information about the meeting, please contact us at email@example.com.
Registration deadline July 20, 2013.
Research symposia supported by the Sharon Stewart Aniridia Trust and the University of Virginia Vice President for Research, Office of the Provost, College and Graduate School of Arts and Sciences, Department of Ophthalmology and Department of Biology. Poster image courtesy of Veronica van Heyningen.